ARTICLE | Clinical News
SURVEYOR Scan K-RAS kit regulatory update
September 20, 2010 7:00 AM UTC
Transgenomic received CE Mark approval in the EU for its SURVEYOR Scan K-RAS kit to detect mutations in K-Ras associated with drug-resistant tumors. The company markets a research use only version of ...